Table 2 Circulating plasma microRNA expression levels in AML patients compared to healthy controls
From: Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
MicroRNA | AML/Healthy control ratio | P value |
|---|---|---|
Hsa-let-7b | 6.5 | 0.021 |
Hsa-let-7d | 0.2 | 0.026 |
Hsa-miR-150 | 0.045 | 0.0026 |
Hsa-miR-335 | 4.5 | 0.041 |
Hsa-miR-339 | 0.4 | 0.031 |
Hsa-miR-342 | 0.07 | 0.0048 |
Hsa-miR-374 | 3.5 | 0.045 |
Hsa-miR-523 | 5 | 0.022 |